EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Synbiotics: An Emerging Frontier in Infectious Diseases Control

Nikita Jangra, Nikita Chahar, Aparna Parmar, Pooja Gulati

Probiotics and Antimicrobial Proteins · 2025

DOI: 10.1007/s12602-025-10690-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Nikita Jangra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Microbiology and Bioprocess Technology Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India. Hauptthemen laut MEDLINE: Synbiotics, Gastrointestinal Microbiome, Communicable Diseases, Communicable Disease Control. Die Arbeit nennt 96 Literaturangaben. Gefördert von: Haryana State Higher Education Council (CM Research Fellowships).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gut microbiome is critical in promoting human health in many aspects, like facilitating nutrient absorption, digestion, immune system regulation, and protecting against pathogens. Gut microbiota dysbiosis is associated with the pathogenesis of several infectious diseases. In this context, a combination of prebiotics and probiotics as synbiotics is emerging as a popular approach for managing immune and gastrointestinal health. Synbiotics have exhibited considerable potency in restoring eubiosis via modulating the gut microbiome. The dietary supplementation of synbiotics has shown promising results in treating infectious diseases like hepatitis, gastroenteritis, dental caries, and sepsis. Synbiotics antagonise pathogens by maintaining gut microbiota homeostasis, competing with pathogenic microorganisms for adhesion and nutrition, producing antimicrobial compounds, and stimulating immunomodulatory cells in vivo. The present article has been conceptualised to understand the potential of synbiotics as an alternative or adjunct to antibiotics in managing infectious diseases. Furthermore, it elaborates on the different formulations of synbiotics available for clinical use and their mode of action. Challenges associated and recent approaches to improve the efficacy of these therapeutics have also been addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynbioticsGastrointestinal MicrobiomeCommunicable DiseasesCommunicable Disease ControlHumansProbioticsAnimalsPrebioticsDysbiosis

Stichwörter der Autor:innen

Clinical applicationsHuman healthInfectious diseasesPrebioticsProbioticsSynbiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Medical Microbiology and Bioprocess Technology Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
  • Department of Microbiology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, 124001, India.
  • Medical Microbiology and Bioprocess Technology Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India. gulatipooja1@gmail.com.

Förderung

  • Haryana State Higher Education Council (CM Research Fellowships)

Zitieren

APA

Jangra, N., Chahar, N., Parmar, A., & Gulati, P. (2025). Synbiotics: An Emerging Frontier in Infectious Diseases Control. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10690-4

Vancouver

Jangra N, Chahar N, Parmar A, Gulati P. Synbiotics: An Emerging Frontier in Infectious Diseases Control. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-025-10690-4

BibTeX
@article{Jangra2025,
  author = {Jangra, Nikita and Chahar, Nikita and Parmar, Aparna and Gulati, Pooja},
  title = {Synbiotics: An Emerging Frontier in Infectious Diseases Control},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  doi = {10.1007/s12602-025-10690-4}
}
Kostenlos starten →